nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—ADRA1A—polycystic ovary syndrome	0.903	1	CbGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	8.58e-05	0.000883	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	8.57e-05	0.000882	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	8.53e-05	0.000878	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	8.51e-05	0.000876	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	8.4e-05	0.000865	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	8.35e-05	0.000859	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	8.33e-05	0.000858	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—GHRL—polycystic ovary syndrome	8.02e-05	0.000826	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FLT4—polycystic ovary syndrome	7.93e-05	0.000816	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	7.89e-05	0.000812	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	7.89e-05	0.000812	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	7.87e-05	0.00081	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	7.87e-05	0.00081	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FLT4—polycystic ovary syndrome	7.8e-05	0.000803	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	7.77e-05	0.000799	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	7.74e-05	0.000797	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	7.73e-05	0.000795	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	7.64e-05	0.000786	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	7.61e-05	0.000783	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	7.58e-05	0.00078	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	7.5e-05	0.000772	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.22e-05	0.000743	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.17e-05	0.000738	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.1e-05	0.000731	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	7.09e-05	0.000729	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.05e-05	0.000726	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.95e-05	0.000715	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	6.93e-05	0.000713	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	6.91e-05	0.000711	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.87e-05	0.000707	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	6.85e-05	0.000705	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.84e-05	0.000704	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NPB—polycystic ovary syndrome	6.82e-05	0.000702	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.76e-05	0.000695	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	6.71e-05	0.000691	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.7e-05	0.000689	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	6.68e-05	0.000687	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	6.64e-05	0.000683	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.62e-05	0.000681	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	6.6e-05	0.00068	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	6.56e-05	0.000675	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	6.53e-05	0.000672	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	6.47e-05	0.000666	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	6.45e-05	0.000664	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.43e-05	0.000662	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	6.4e-05	0.000658	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.33e-05	0.000652	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.31e-05	0.00065	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.27e-05	0.000645	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	6.24e-05	0.000642	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.21e-05	0.000639	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.2e-05	0.000638	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.17e-05	0.000635	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.16e-05	0.000634	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.14e-05	0.000632	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—LHB—polycystic ovary syndrome	6.14e-05	0.000631	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.09e-05	0.000627	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.08e-05	0.000626	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.06e-05	0.000624	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.04e-05	0.000622	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.04e-05	0.000622	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	6.01e-05	0.000618	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6e-05	0.000617	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	5.93e-05	0.000611	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	5.91e-05	0.000609	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.88e-05	0.000605	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.87e-05	0.000604	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	5.84e-05	0.000601	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.79e-05	0.000595	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.79e-05	0.000595	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—SCT—polycystic ovary syndrome	5.75e-05	0.000592	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.69e-05	0.000586	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.69e-05	0.000586	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	5.63e-05	0.000579	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.57e-05	0.000574	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.57e-05	0.000574	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.57e-05	0.000574	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.49e-05	0.000565	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.44e-05	0.00056	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.41e-05	0.000557	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.37e-05	0.000553	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.36e-05	0.000551	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.32e-05	0.000548	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.25e-05	0.000541	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.25e-05	0.00054	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.21e-05	0.000537	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.17e-05	0.000532	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.11e-05	0.000526	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.06e-05	0.000521	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.03e-05	0.000518	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	4.98e-05	0.000513	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.92e-05	0.000507	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.9e-05	0.000504	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.8e-05	0.000494	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.65e-05	0.000478	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.57e-05	0.000471	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.53e-05	0.000467	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.48e-05	0.000461	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.46e-05	0.000459	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.37e-05	0.00045	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	4.23e-05	0.000436	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	4.17e-05	0.000429	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	4.15e-05	0.000427	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.12e-05	0.000424	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	4.08e-05	0.00042	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	4.08e-05	0.00042	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.06e-05	0.000418	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.05e-05	0.000417	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.99e-05	0.000411	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.98e-05	0.00041	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.97e-05	0.000408	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.92e-05	0.000403	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.87e-05	0.000399	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.84e-05	0.000395	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.81e-05	0.000392	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	3.77e-05	0.000388	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.75e-05	0.000386	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.73e-05	0.000384	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	3.71e-05	0.000382	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.69e-05	0.00038	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	3.68e-05	0.000379	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.67e-05	0.000378	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	3.64e-05	0.000374	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	3.62e-05	0.000373	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.62e-05	0.000372	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.6e-05	0.000371	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.59e-05	0.00037	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	3.55e-05	0.000365	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.54e-05	0.000365	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.49e-05	0.000359	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.48e-05	0.000358	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.47e-05	0.000357	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	3.45e-05	0.000355	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.43e-05	0.000353	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.42e-05	0.000352	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.41e-05	0.000351	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	3.4e-05	0.00035	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	3.37e-05	0.000347	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.36e-05	0.000346	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.35e-05	0.000345	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.35e-05	0.000345	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	3.33e-05	0.000342	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.29e-05	0.000339	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.28e-05	0.000338	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.24e-05	0.000333	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.24e-05	0.000333	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.21e-05	0.00033	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	3.18e-05	0.000328	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.17e-05	0.000327	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.16e-05	0.000325	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	3.16e-05	0.000325	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.14e-05	0.000324	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	3.12e-05	0.000321	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.11e-05	0.00032	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	3.09e-05	0.000318	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.08e-05	0.000317	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.04e-05	0.000313	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	3e-05	0.000308	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.95e-05	0.000304	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.95e-05	0.000303	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.91e-05	0.000299	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.89e-05	0.000297	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.85e-05	0.000293	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	2.83e-05	0.000291	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	2.78e-05	0.000286	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.72e-05	0.00028	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.68e-05	0.000276	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.64e-05	0.000272	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.64e-05	0.000272	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	2.62e-05	0.000269	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.6e-05	0.000268	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.59e-05	0.000266	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	2.57e-05	0.000265	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.55e-05	0.000262	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.52e-05	0.000259	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.43e-05	0.00025	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.43e-05	0.00025	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.39e-05	0.000246	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.39e-05	0.000246	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.34e-05	0.000241	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.34e-05	0.000241	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.34e-05	0.000241	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.32e-05	0.000239	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.31e-05	0.000237	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.28e-05	0.000235	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.26e-05	0.000233	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.26e-05	0.000232	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.25e-05	0.000232	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.24e-05	0.00023	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.23e-05	0.000229	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.22e-05	0.000228	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.18e-05	0.000224	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.17e-05	0.000223	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.14e-05	0.00022	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.13e-05	0.000219	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	2.12e-05	0.000218	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.11e-05	0.000217	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.09e-05	0.000215	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	2.09e-05	0.000215	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.06e-05	0.000212	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.05e-05	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.05e-05	0.00021	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	2.04e-05	0.00021	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.01e-05	0.000207	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.01e-05	0.000207	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.98e-05	0.000204	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.97e-05	0.000203	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.94e-05	0.0002	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.87e-05	0.000192	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.84e-05	0.000189	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.8e-05	0.000185	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.78e-05	0.000183	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.75e-05	0.00018	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.75e-05	0.00018	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.72e-05	0.000177	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.71e-05	0.000176	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.68e-05	0.000173	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.5e-05	0.000154	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.47e-05	0.000151	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	1.46e-05	0.000151	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.44e-05	0.000148	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.44e-05	0.000148	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.41e-05	0.000145	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.31e-05	0.000134	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.28e-05	0.000132	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.26e-05	0.000129	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	1.26e-05	0.000129	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.24e-05	0.000127	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	1.23e-05	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.21e-05	0.000125	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.21e-05	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.21e-05	0.000124	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.2e-05	0.000124	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.19e-05	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.19e-05	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.16e-05	0.00012	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.16e-05	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.15e-05	0.000118	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.13e-05	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.11e-05	0.000114	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	9.25e-06	9.52e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	9.1e-06	9.36e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	8.91e-06	9.17e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.9e-06	8.13e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.77e-06	8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.61e-06	7.83e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	5.46e-06	5.62e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	5.37e-06	5.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	5.26e-06	5.42e-05	CbGpPWpGaD
